1,333 articles
A wave of cardiology findings reshapes heart failure diagnosis, reveals stroke drug promise, and links social ties to longevity.
A roundup of endocrinology breakthroughs: GLP-1s post-surgery, vitamin D cutting diabetes risk, and resistance training protecting 140,000 professionals.
A large VA study finds SGLT2 inhibitors cut dementia risk by nearly 40% in older adults with depression, bipolar disorder, or schizophrenia.
A major Swedish study finds immunosuppressed adults face dramatically higher odds of HPV-linked cancers, reinforcing urgent vaccination and screening needs.
Higher vitamin A levels tied to stronger lung capacity across age groups, with vitamin D showing benefits in adults too.
Scientists discover how toxic Tau hijacks a natural brain communication system to spread Alzheimer's disease cell to cell.
Researchers from Northeastern and Harvard mapped 6,442 drugs against aging hallmark genes using protein interaction networks to identify longevity candidates.
A Phase 3 trial testing a single-injection gene therapy for wet AMD finished enrollment 4 months early, with results due in 2027.
United Therapeutics wins FDA approval for LungFX, a device that keeps donor lungs viable outside the body for transplant reassessment.
DiamiR and AlzLabs are combining protein biomarkers with microRNA signatures to match PET scan accuracy using a simple blood draw.
A London startup uses machine learning to stop cells silencing gene therapies, potentially cutting doses and extending treatment durability.
USC researchers unlocked a scalable supply of engineered immune-cell precursors that fight tumors and may revolutionize cancer immunotherapy.
